PharVision Advisers’s Coty COTY Stock Holding History

PharVision Advisers’s Portfolio COTY Stock Details COTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-51,690	Closed	-$159K	–	224
2025 Q4	$159K	Buy	+51,690	New	+$188K	0.08%	606

Other funds holding COTY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's COTY Position: Q1 2026 in Review

PharVision Advisers sold out of Coty (COTY) in Q1 2026, closing a stake of 51,690 shares — an estimated $159K sold.

PharVision Advisers first reported a position in COTY in Q4 2025 and held it in 1 quarter. The position peaked at $159K in Q4 2025. 326 funds tracked by Wall St. Rank hold COTY as of Q1 2026.

PharVision Advisers reported no remaining Coty position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 51,690 Coty shares in Q1 2026, an estimated $159K.
PharVision Advisers first reported a position in Coty in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Coty position peaked at $159K in Q4 2025.
326 funds tracked by Wall St. Rank held Coty as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.